antiplatelet agentshttp://www.unboundmedicine.com/medline/ebm/research/antiplatelet_agentsUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors.http://www.unboundmedicine.com/medline/ebm/record/19923312/full_citation/Review_of_recent_evidence:_Potential_interaction_between_clopidogrel_and_proton_pump_inhibitors_Last EJ, Sheehan AH 
Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors. [JOURNAL ARTICLE]
Am J Health Syst Pharm 2009 Dec 1; 66(23):2117-2122.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers.http://www.unboundmedicine.com/medline/ebm/record/19922880/full_citation/Potential_interactions_between_cilostazol_and_probucol:_A_two_part_single_dose_open_label_study_in_healthy_Korean_male_volunteers_Kim KP, Kim BH, Lim KS, et al. 
Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers. [JOURNAL ARTICLE]
Clin Ther 2009 Oct; 31(10):2098-2106.
Abstract | Full Citation | Find Related Articles [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!]http://www.unboundmedicine.com/medline/ebm/record/19914029/full_citation/[Prevention_of_GI_bleeding_due_to_antiplatelet_agents:_a_labyrinth]Bretagne JF 
[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!] [EDITORIAL]
Presse Med 2009 Nov 12.
Full Citation | Find Related Articles Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.http://www.unboundmedicine.com/medline/ebm/record/19912320/full_citation/Influence_of_antiplatelet_pre_treatment_on_the_risk_of_intracranial_haemorrhage_in_acute_ischaemic_stroke_after_intravenous_thrombolysis_Dorado L, Millán M, de la Ossa NP, et al. 
Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis. [JOURNAL ARTICLE]
Eur J Neurol 2009 Nov 12.
Abstract | Full Citation | Find Related Articles Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase.http://www.unboundmedicine.com/medline/ebm/record/19912226/full_citation/Platelet_aggregation_responses_are_critically_regulated_in_vivo_by_endogenous_nitric_oxide_but_not_by_endothelial_nitric_oxide_synthase_Tymvios C, Moore C, Jones S, et al. 
Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. [JOURNAL ARTICLE]
Br J Pharmacol 2009 Nov 12.
Abstract | Full Citation | Find Related Articles Advances in Antiplatelet Treatment for Acute Coronary Syndromes.http://www.unboundmedicine.com/medline/ebm/record/19910292/full_citation/Advances_in_Antiplatelet_Treatment_for_Acute_Coronary_Syndromes_Kaul S, Eshaghian S, Shah PK 
Advances in Antiplatelet Treatment for Acute Coronary Syndromes. [JOURNAL ARTICLE]
Heart 2009 Nov 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles The Antiplatelet Effect of Aspirin is Reduced by Proton Pump Inhibitors in Patients With Coronary Artery Disease.http://www.unboundmedicine.com/medline/ebm/record/19910291/full_citation/The_Antiplatelet_Effect_of_Aspirin_is_Reduced_by_Proton_Pump_Inhibitors_in_Patients_With_Coronary_Artery_Disease_Würtz M, Grove EL, Kristensen SD, et al. 
The Antiplatelet Effect of Aspirin is Reduced by Proton Pump Inhibitors in Patients With Coronary Artery Disease. [JOURNAL ARTICLE]
Heart 2009 Nov 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles A Systematic Review of Implementation of Established Recommended Secondary Prevention Measures in Patients with PAOD.http://www.unboundmedicine.com/medline/ebm/record/19910222/full_citation/A_Systematic_Review_of_Implementation_of_Established_Recommended_Secondary_Prevention_Measures_in_Patients_with_PAOD_Flu HC, Tamsma JT, Lindeman JH, et al. 
A Systematic Review of Implementation of Established Recommended Secondary Prevention Measures in Patients with PAOD. [JOURNAL ARTICLE]
Eur J Vasc Endovasc Surg 2009 Nov 10.
Abstract | Full CitationUnderutilisation of cardiovascular medications among at-risk individuals.http://www.unboundmedicine.com/medline/ebm/record/19909379/full_citation/Underutilisation_of_cardiovascular_medications_among_at_risk_individuals_Lewis SJ, Robinson JG, Fox KM, et al. 
Underutilisation of cardiovascular medications among at-risk individuals. [JOURNAL ARTICLE]
Int J Clin Pract 2009 Nov 11.
Abstract | Full Citation | Find Related Articles Enhancement of fibrinolysis by gel-filtered platelets and its quenching by cytochalasin B and GPIIb/IIIa antagonists.http://www.unboundmedicine.com/medline/ebm/record/19904011/full_citation/Enhancement_of_fibrinolysis_by_gel_filtered_platelets_and_its_quenching_by_cytochalasin_B_and_GPIIb/IIIa_antagonists_Hoki S, Suzuki Y, Umemura K, et al. 
Enhancement of fibrinolysis by gel-filtered platelets and its quenching by cytochalasin B and GPIIb/IIIa antagonists. [JOURNAL ARTICLE]
Pharmacol Rep 2009 September-October; 61(5):877-884.
Abstract | Full Citation